Page 1 Bacterial vaccines in clinical and preclinical development 2021 An overview and analysis
World Health Organization Page 2 Bacterial vaccines in clinical and preclinical development 2021 …

Vaccines are one of the most useful and cost-effective tools for reducing the morbidity and
mortality that are associated with infectious diseases. Here, Jeffrey Almond discusses the …

Genome-based reverse vaccinology (RV) is a multi-step experimental strategy which starts
from in silico analysis of whole genome sequences, from which vaccine candidates can be …

Increasing antibiotic resistance in bacteria causing endogenous infections has entailed a
need for innovative approaches to therapy and prophylaxis of these infections and raised a …

Infectious diseases are the greatest cause of global morbidity and mortality. About half of this
burden is caused by pathogenic bacteria. One of the most effective ways to prevent …

The last big outbreaks of Ebola fever in Africa, the thousands of avian influenza outbreaks
across Europe, Asia, North America and Africa, the emergence of monkeypox virus in …

Before the development of the first vaccine, infectious diseases were a major cause of death
around the globe with life expectancy estimated to be< 50 years. Three measures have …

In the 18th century, English physician Edward Jenner laid the foundation for modern
vaccination by achieving protection against variola. His observations led to the development …

The World Health Organization has named vaccine hesitancy as one of the top ten threats to
global health in 2019. The reasons why people choose not to vaccinate are complex, but …

Vaccines can be highly effective tools in combating antimicrobial resistance as they reduce
infections caused by antibiotic-resistant bacteria and antibiotic consumption associated with …